KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Equity Ratio (2016 - 2025)

Thermo Fisher Scientific's Equity Ratio history spans 17 years, with the latest figure at 0.48 for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio fell 4.92% year-over-year to 0.48, compared with a TTM value of 0.48 through Dec 2025, down 4.92%, and an annual FY2025 reading of 0.48, down 4.92% over the prior year.
  • Equity Ratio for Q4 2025 was 0.48 at Thermo Fisher Scientific, down from 0.5 in the prior quarter.
  • The five-year high for Equity Ratio was 0.55 in Q3 2021, with the low at 0.43 in Q4 2021.
  • Average Equity Ratio over 5 years is 0.48, with a median of 0.48 recorded in 2024.
  • Year-over-year, Equity Ratio rose 12.38% in 2021 and then fell 16.85% in 2022.
  • Tracing TMO's Equity Ratio over 5 years: stood at 0.43 in 2021, then increased by 5.52% to 0.45 in 2022, then grew by 4.42% to 0.47 in 2023, then grew by 7.58% to 0.51 in 2024, then fell by 4.92% to 0.48 in 2025.
  • Per Business Quant, the three most recent readings for TMO's Equity Ratio are 0.48 (Q4 2025), 0.5 (Q3 2025), and 0.5 (Q2 2025).